TOP TIERMARKET NEWSWIRE
News & sentiment

GENERATE BIOMEDICINE (GENB) — News & AI sentiment

GENERATE BIOMEDICINE (GENB) news roundup. 1 story in the last 24 hours, 8 in the past week, 10 over 30 days. Average 24-hour sentiment is 63/100 — bullish-leaning (50 is neutral). No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
1
avg sentiment 63/100
7d stories
8
avg sentiment 53.3/100
30d stories
10
avg sentiment 53.7/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on GENB

Generate Biomedicines, Inc. reports Q2 results
Seeking Alpha50 · neutralearnings
1d ago
1d ago
1d ago
1d ago
2d ago
2d ago
2d ago
Jul 30
Jul 23
Jul 22
Jul 8
Jul 7
Jul 6
Jun 23
Jun 22
Jun 7
Jun 3
May 28
May 28
May 26
May 7
Open GENB in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →